nach oben

Reactions Weekly

Erschienen in:

01.07.2018 | Case report

Fluoxetine

Anxiety: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

An open label pilot study described a patient [age and sex not stated], who developed anxiety during treatment with fluoxetine to reduce pulmonary vascular resistance [route, duration of treatment to reaction onset and outcome not stated]. The patient, who was on stable PAH therapy, started receiving treatment with fluoxetine 20mg once a day. The treatment was discontinued due to fluoxetine-associated anxiety. …

Sodimu A, et al. Hemodynamic effects of fluoxetine in pulmonary arterial hypertension (PAH)-an open label pilot study. American Journal of Respiratory and Critical Care Medicine 197: no pagination abstr. A5701, Jan 2018. Available from: URL: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A5701 [abstract] - USA

Titel: Fluoxetine
Anxiety: case report
Publikationsdatum: 01.07.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-49535-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Fluoxetine

Anxiety: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Afatinib

Posaconazole/vincristine interaction

Azathioprine/prednisone

Prednisone

Sirolimus

Hydroxychloroquine/infliximab/methotrexate